Botanix Pharmaceuticals (ASX:BOT) Beginning Cash Position : A$10.25 Mil (As of Dec. 2023)

View and export this data going back to 1985. Start your Free Trial

What is Botanix Pharmaceuticals Beginning Cash Position?

Botanix Pharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2023 was A$10.25 Mil.

Botanix Pharmaceuticals's quarterly Beginning Cash Position increased from Dec. 2022 (A$7.29 Mil) to Jun. 2023 (A$8.72 Mil) and increased from Jun. 2023 (A$8.72 Mil) to Dec. 2023 (A$10.25 Mil).

Botanix Pharmaceuticals's annual Beginning Cash Position declined from Jun. 2021 (A$24.65 Mil) to Jun. 2022 (A$21.56 Mil) and declined from Jun. 2022 (A$21.56 Mil) to Jun. 2023 (A$7.29 Mil).

Botanix Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Botanix Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals Beginning Cash Position Chart

Botanix Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Beginning Cash Position

Get a 7-Day Free Trial

17.26

4.70

24.65

21.56

7.29

Botanix Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															21.56	16.85	7.29	8.72	10.25

Botanix Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Botanix Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Botanix Pharmaceuticals (ASX:BOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (ASX:BOT) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

BXPHF:USA

Address

661 Newcastle Street, D2, LEEDERVILLE, WA, AUS, 6007

Website

https://www.botanixpharma.com

Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals (ASX:BOT) Headlines

No Headlines